Joint venture for alternative omega-3 source
Norwegian fish farm in a fjord near Trondheim
Royal DSM and Evonik are set to establish a joint venture for omega-3 fatty acid products from natural marine algae for animal nutrition.
This will enable the production of omega-3 fatty acids for animal nutrition without using fish oil from wild caught fish. It will be the first alternative to offer EPA and DHA.
DSM Nutritional Products and Evonik Nutrition & Care will each hold a 50% share in the joint venture and co-own the production facility, which will be built at an existing site of Evonik and is expected to come on stream in 2019.
The joint venture, to be named Veramaris, plans to invest around US$ 200 million in the facility, with an initial annual production capacity which will meet roughly 15% of the total current annual demand for EPA and DHA by the salmon aquaculture industry.
The algal oil from DSM and Evonik means that the vision of salmon farming without using fish-based resources is – for the first time – becoming realistic.
By replacing fish oil in salmon feed with this EPA and DHA rich alternative, the fish-in-fish-out ratio could be reduced significantly. This alternative will enable the aquaculture industry to continue to grow sustainably.
Most of the fish oil is used in aquaculture, mainly for fat-rich fish species, such as salmon. The limited wild fish stocks restrict the amount of fish oil available and thus the growth of the aquaculture industry.
Currently, the industry uses about 75% of the annual production of fish oil but the ventures algal oil will offer a sustainable non-fish alternative.
Links to related companies and recent articles ...
Images for this article - click to enlargeImage copyright © Mercator Media 2017, or image used with permission of the copyright holder unless otherwise stated.
Royal DSM and Evonik are